CARBOGEN AMCIS

CARBOGEN AMCIS Announces Two Successful FDA Inspections at its Manufacturing Sites in Neuland and Aarau, Switzerland

23 July 2024 — Bubendorf, Switzerland — Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of US Food and Drug Administration (FDA) inspections at its Neuland and Aarau sites.  The FDA conducted routine inspections over five days in Neuland from 17-21…

CARBOGEN AMCIS announces successful ANVISA audit of its facility in China

19 March 2024 — Bubendorf, Switzerland — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its facility in Shanghai, China. Between 6-10 November 2023, a five-day inspection was undertaken, which concluded successfully with no…
Hauptstrasse 171 CH-4416 Bubendorf Switzerland

+41 58 909 00 00